Entry |
|
Name |
Felbamate (USPINN); Felbatol (TN) |
Product |
|
Generic |
FELBAMATE (ANI Pharmaceuticals), FELBAMATE (Alvogen), FELBAMATE (Amneal Pharmaceuticals LLC), FELBAMATE (Amneal Pharmaceuticals of New York LLC), FELBAMATE (Bryant Ranch Prepack), FELBAMATE (Bryant Ranch Prepack), FELBAMATE (Bryant Ranch Prepack), FELBAMATE (Bryant Ranch Prepack), FELBAMATE (NORTHSTAR RX LLC), FELBAMATE (Novitium Pharma LLC), FELBAMATE (Taro Pharmaceuticals U.S.A.), FELBAMATE (Taro Pharmaceuticals U.S.A.), FELBAMATE (Viona Pharmaceuticals), FELBAMATE (Wallace Pharmaceuticals), FELBAMATE (Zydus Lifesciences Limited) |
Formula |
C11H14N2O4
|
Exact mass |
238.0954
|
Mol weight |
238.2399
|
Structure |
|
Simcomp |
|
Remark |
|
Efficacy |
Antiepileptic |
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Interaction |
|
Structure map |
|
Other map |
map00982 | Drug metabolism - cytochrome P450 |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AX Other antiepileptics
N03AX10 Felbamate
D00536 Felbamate (USPINN) <US>
USP drug classification [BR:br08302]
Anticonvulsants
Anticonvulsants, Other
Felbamate
D00536 Felbamate (USPINN)
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
Glutamate (ionotropic), NMDA
GRIN (NMDAR)
D00536 Felbamate (USPINN) <US>
|
Other DBs |
|
KCF data |
ATOM 17
1 C1c C 22.8142 -18.8475
2 C8y C 22.8258 -17.4532
3 C1b C 21.6008 -19.5416
4 C1b C 24.0275 -19.5476
5 C8x C 21.6125 -16.7475
6 C8x C 24.0392 -16.7532
7 O7a O 20.3933 -18.8416
8 O7a O 25.2408 -18.8533
9 C8x C 21.6125 -15.3417
10 C8x C 24.0450 -15.3474
11 C7a C 19.1800 -19.5300
12 C7a C 26.4543 -19.5533
13 C8x C 22.8317 -14.6474
14 N1a N 17.9724 -18.8359
15 O6a O 19.1741 -20.9359
16 N1a N 27.6618 -18.8592
17 O6a O 26.4543 -20.9593
BOND 17
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 4 8 1
8 5 9 1
9 6 10 2
10 7 11 1
11 8 12 1
12 9 13 2
13 11 14 1
14 11 15 2
15 12 16 1
16 12 17 2
17 10 13 1
|